可切除肝转移瘤的围手术期化疗 - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

可切除肝转移瘤的围手术期化疗 - Suppr | 超能文献

Perioperative chemotherapy for resectable hepatic metastases.

作者信息

Kopetz Scott, Vauthey Jean-Nicolas

机构信息

Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Lancet. 2008 Mar 22;371(9617):963-5. doi: 10.1016/S0140-6736(08)60429-8.

DOI:10.1016/S0140-6736(08)60429-8

Abstract

摘要

相似文献

1

Perioperative chemotherapy for resectable hepatic metastases.可切除肝转移瘤的围手术期化疗

Lancet. 2008 Mar 22;371(9617):963-5. doi: 10.1016/S0140-6736(08)60429-8.

2

What is the standard chemotherapy for colorectal cancer patients with resectable liver metastases?对于可切除肝转移的结直肠癌患者，标准化疗方案是什么？

Nat Clin Pract Oncol. 2009 Jan;6(1):14-6. doi: 10.1038/ncponc1274. Epub 2008 Nov 11.

3

[State of art of the radiofrequency ablation of colorectal liver metastases].[结直肠癌肝转移灶的射频消融技术现状]

Zhonghua Zhong Liu Za Zhi. 2011 Jun;33(6):401-4.

4

Predictive factors for the benefit of perioperative FOLFOX for resectable liver metastasis in colorectal cancer patients (EORTC Intergroup Trial 40983).预测因素分析可切除结直肠癌肝转移患者围手术期 FOLFOX 方案（EORTC 国际多中心临床试验 40983）的获益。

Ann Surg. 2012 Mar;255(3):534-9. doi: 10.1097/SLA.0b013e3182456aa2.

5

The timing of surgery for resectable metachronous liver metastases from colorectal cancer: Better sooner than later? A retrospective analysis.结直肠癌可切除肝转移术后再次手术时机：尽早优于晚些？一项回顾性分析。

Dig Liver Dis. 2011 Mar;43(3):194-8. doi: 10.1016/j.dld.2010.07.003. Epub 2010 Aug 21.

6

Improved first-line chemotherapy: a better chance for surgery?一线化疗的改进：手术机会是否增加？

Lancet Oncol. 2010 Jan;11(1):4-5. doi: 10.1016/S1470-2045(09)70345-6. Epub 2009 Nov 26.

7

Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.结直肠癌原发可切除肝转移患者中每周高剂量氟尿嘧啶（24 小时输注）、亚叶酸钙和每两周奥沙利铂的新辅助治疗：一项 II 期试验的长期结果。

Med Sci Monit. 2010 Feb;16(2):CR49-55.

8

Chemotherapy for the conversion of unresectable colorectal cancer liver metastases to resection.结直肠癌肝转移不可切除者的转化化疗。

Crit Rev Oncol Hematol. 2011 Sep;79(3):251-64. doi: 10.1016/j.critrevonc.2010.08.001. Epub 2010 Oct 22.

9

Management of patients with synchronous liver metastases of colorectal cancer. Clinical practice guidelines. Guidelines of the French society of gastrointestinal surgery (SFCD) and of the association of hepatobiliary surgery and liver transplantation (ACHBT). Short version.结直肠癌同时性肝转移患者的管理。临床实践指南。法国胃肠外科学会（SFCD）及肝胆外科学与肝移植协会（ACHBT）指南。简版

J Visc Surg. 2011 Jun;148(3):e171-82. doi: 10.1016/j.jviscsurg.2011.05.015. Epub 2011 Jun 24.

10

Outcome of metastatic colorectal cancer: analysis of a consecutive series of 229 patients. The impact of a multidisciplinary approach.转移性结直肠癌的预后：对229例连续病例的分析。多学科治疗方法的影响。

Dis Colon Rectum. 2006 Oct;49(10):1596-601. doi: 10.1007/s10350-006-0662-7.

引用本文的文献

1

Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases.无论切缘状态还是体突变都不能预测结直肠肝转移 R0 切除术后局部复发。

J Gastrointest Surg. 2022 Apr;26(4):791-801. doi: 10.1007/s11605-021-05173-0. Epub 2021 Nov 1.

2

Cancer and liver cirrhosis: implications on prognosis and management.癌症与肝硬化：对预后及治疗的影响

ESMO Open. 2016 Mar 17;1(2):e000042. doi: 10.1136/esmoopen-2016-000042. eCollection 2016.

3

SSAT State-of-the-Art Conference: New Frontiers in Liver Surgery.

SSAT 前沿技术会议：肝脏手术新前沿

J Gastrointest Surg. 2017 Jan;21(1):175-185. doi: 10.1007/s11605-016-3193-0. Epub 2016 Aug 1.

4

Prognostic factors after resection of colorectal liver metastases following preoperative second-line chemotherapy: Impact of RAS mutations.术前二线化疗后结直肠癌肝转移灶切除术后的预后因素：RAS 突变的影响

Eur J Surg Oncol. 2016 Sep;42(9):1378-84. doi: 10.1016/j.ejso.2016.02.249. Epub 2016 Mar 5.

5

Surgical Management of Colorectal Liver Metastases: Prognostic Indicators and the Impact of RAS Mutation Status.结直肠癌肝转移的外科治疗：预后指标及RAS突变状态的影响

J Adv Pract Oncol. 2015 Sep-Oct;6(5):460-6. doi: 10.6004/jadpro.2015.6.5.6. Epub 2015 Sep 1.

6

Predictors of Safety and Efficacy of 2-Stage Hepatectomy for Bilateral Colorectal Liver Metastases.双侧结直肠癌肝转移患者二期肝切除安全性和疗效的预测因素

J Am Coll Surg. 2016 Jul;223(1):99-108. doi: 10.1016/j.jamcollsurg.2015.12.057. Epub 2016 Jan 18.

7

Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial Findings.将化疗纳入寡转移性结直肠癌的管理：基于临床试验结果的循证方法。

Ann Surg Oncol. 2015 Dec;22 Suppl 3(0 3):S855-62. doi: 10.1245/s10434-015-4610-4. Epub 2015 Jun 23.

8

"Vanishing liver metastases"-A real challenge for liver surgeons.“消失的肝转移瘤”——肝外科医生面临的真正挑战。

Hepatobiliary Surg Nutr. 2014 Oct;3(5):295-302. doi: 10.3978/j.issn.2304-3881.2014.09.13.

9

RAS mutations predict radiologic and pathologic response in patients treated with chemotherapy before resection of colorectal liver metastases.RAS突变可预测在结直肠肝转移灶切除术前接受化疗的患者的放射学和病理学反应。

Ann Surg Oncol. 2015 Mar;22(3):834-842. doi: 10.1245/s10434-014-4042-6. Epub 2014 Sep 17.

10

Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy.回归预期肿瘤治疗（RIOT）：一种评估恶性肿瘤手术治疗质量的新指标。

J Surg Oncol. 2014 Aug;110(2):107-14. doi: 10.1002/jso.23626. Epub 2014 May 21.